Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility-Reference-Cited by-同舟云学术

Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility

Published:2007-03-06 Issue:9 Volume:16 Page:1051-1057
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Johnson Nichola,Fletcher Olivia,Palles Claire,Rudd Matthew,Webb Emily,Sellick Gabrielle,dos Santos Silva Isabel,McCormack Valerie,Gibson Lorna,Fraser Agnes,Leonard Angela,Gilham Clare,Tavtigian Sean V.,Ashworth Alan,Houlston Richard,Peto Julian

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/16/9/1051/17244140/ddm050.pdf

Reference37 articles.

1. High constant incidence in twins and other relatives of women with breast cancer;Peto;Nat. Genet.,2000

2. Association studies for finding cancer-susceptibility genetic variants;Pharoah;Nat. Rev. Cancer,2004

3. Cancer genetics;Ponder;Nature,2001

4. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early onset breast cancer;Peto;J. Natl. Cancer Inst.,1999

5. Polygenic susceptibility to breast cancer and implications for prevention;Pharoah;Nat. Genet.,2002

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline variant profiling of CHEK2 sequencing variants in breast cancer patients;Cancer Genetics;2024-11

2. Evaluation of the BRCA2 Gene Variants Association with the Risk of Breast Cancer in the Iranian Population;Jentashapir Journal of Cellular and Molecular Biology;2024-07-14

3. Unraveling precision exercise: A journey from efficacy to molecular insights;Advanced Exercise and Health Science;2024-03

4. T Cell Receptor Protein Sequences and Sparse Coding: A Novel Approach to Cancer Classification;Communications in Computer and Information Science;2023-11-26

5. Breast cancer: genetic personal risk factors: A review;Journal of Modern Oncology;2023-08-10